A citation-based method for searching scientific literature

Tomonari Kinoshita, Taichiro Goto. Int J Mol Sci 2019
Times Cited: 29







List of co-cited articles
115 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets.
Beatriz Ballester, Javier Milara, Julio Cortijo. Int J Mol Sci 2019
66
17

Idiopathic pulmonary fibrosis.
Luca Richeldi, Harold R Collard, Mark G Jones. Lancet 2017
499
13

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
13

Idiopathic pulmonary fibrosis.
Talmadge E King, Annie Pardo, Moisés Selman. Lancet 2011
13


Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.
John Hutchinson, Andrew Fogarty, Richard Hubbard, Tricia McKeever. Eur Respir J 2015
343
10


Immune Mechanisms in Pulmonary Fibrosis.
Saeed Kolahian, Isis E Fernandez, Oliver Eickelberg, Dominik Hartl. Am J Respir Cell Mol Biol 2016
104
10


Pre-existing pulmonary fibrosis is a risk factor for anti-PD-1-related pneumonitis in patients with non-small cell lung cancer: A retrospective analysis.
Teppei Yamaguchi, Junichi Shimizu, Takaaki Hasegawa, Yoshitsugu Horio, Yoshitaka Inaba, Yasushi Yatabe, Toyoaki Hida. Lung Cancer 2018
47
10

Simple method of estimating severity of pulmonary fibrosis on a numerical scale.
T Ashcroft, J M Simpson, V Timbrell. J Clin Pathol 1988
903
10

Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice.
Jingsong Zhao, Wei Shi, Yan-Ling Wang, Hui Chen, Pablo Bringas, Michael B Datto, Joshua P Frederick, Xiao-Fan Wang, David Warburton. Am J Physiol Lung Cell Mol Physiol 2002
297
10

Cumulative incidence of and predictive factors for lung cancer in IPF.
Yuichi Ozawa, Takafumi Suda, Tateaki Naito, Noriyuki Enomoto, Dai Hashimoto, Tomoyuki Fujisawa, Yutaro Nakamura, Naoki Inui, Hirotoshi Nakamura, Kingo Chida. Respirology 2009
168
10

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
10

Idiopathic Pulmonary Fibrosis.
David J Lederer, Fernando J Martinez. N Engl J Med 2018
451
10

Idiopathic pulmonary fibrosis: pathogenesis and management.
Giacomo Sgalla, Bruno Iovene, Mariarosaria Calvello, Margherita Ori, Francesco Varone, Luca Richeldi. Respir Res 2018
139
10


Mechanisms of pulmonary fibrosis.
Victor J Thannickal, Galen B Toews, Eric S White, Joseph P Lynch, Fernando J Martinez. Annu Rev Med 2004
440
10

The pathogenesis of idiopathic pulmonary fibrosis.
William R Coward, Gauri Saini, Gisli Jenkins. Ther Adv Respir Dis 2010
179
10

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.
Peter M George, Athol U Wells, R Gisli Jenkins. Lancet Respir Med 2020
351
10

Metformin reverses established lung fibrosis in a bleomycin model.
Sunad Rangarajan, Nathaniel B Bone, Anna A Zmijewska, Shaoning Jiang, Dae Won Park, Karen Bernard, Morgan L Locy, Saranya Ravi, Jessy Deshane, Roslyn B Mannon,[...]. Nat Med 2018
190
6

Idiopathic pulmonary fibrosis.
Fernando J Martinez, Harold R Collard, Annie Pardo, Ganesh Raghu, Luca Richeldi, Moises Selman, Jeffrey J Swigris, Hiroyuki Taniguchi, Athol U Wells. Nat Rev Dis Primers 2017
326
6

Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors.
Laszlo Farkas, Jack Gauldie, Norbert F Voelkel, Martin Kolb. Am J Respir Cell Mol Biol 2011
135
6

An Open-Label Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (RECAP).
Ulrich Costabel, Carlo Albera, Lisa H Lancaster, Chin-Yu Lin, Philip Hormel, Henry N Hulter, Paul W Noble. Respiration 2017
69
6

Pulmonary fibrosis: pathogenesis, etiology and regulation.
M S Wilson, T A Wynn. Mucosal Immunol 2009
429
6

The basics of epithelial-mesenchymal transition.
Raghu Kalluri, Robert A Weinberg. J Clin Invest 2009
6


TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.
Yang Hao, David Baker, Peter Ten Dijke. Int J Mol Sci 2019
234
6

Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review.
Tatsuo Kanda, Taichiro Goto, Yosuke Hirotsu, Mitsuhiko Moriyama, Masao Omata. Int J Mol Sci 2019
84
6

Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer.
Argyris Tzouvelekis, Georgia Gomatou, Evangelos Bouros, Rodoula Trigidou, Vasilios Tzilas, Demosthenes Bouros. Chest 2019
29
6

Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses.
Alice Guyard, Claire Danel, Nathalie Théou-Anton, Marie-Pierre Debray, Laure Gibault, Pierre Mordant, Yves Castier, Bruno Crestani, Gérard Zalcman, Hélène Blons,[...]. Respir Res 2017
20
10


A pilot trial of nivolumab treatment for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia.
Daichi Fujimoto, Takeshi Morimoto, Jiro Ito, Yuki Sato, Munehiro Ito, Shunsuke Teraoka, Kojiro Otsuka, Kazuma Nagata, Atsushi Nakagawa, Keisuke Tomii. Lung Cancer 2017
39
6


Durable response to nivolumab in a lung adenocarcinoma patient with idiopathic pulmonary fibrosis.
Maako Ide, Kentaro Tanaka, Shunya Sunami, Tatsuma Asoh, Takashige Maeyama, Nobuko Tsuruta, Yoichi Nakanishi, Isamu Okamoto. Thorac Cancer 2018
12
16

Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada.
Robert B Hopkins, Natasha Burke, Charlene Fell, Genevieve Dion, Martin Kolb. Eur Respir J 2016
71
6

The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.
Phillip L Molyneaux, Michael J Cox, Saffron A G Willis-Owen, Patrick Mallia, Kirsty E Russell, Anne-Marie Russell, Elissa Murphy, Sebastian L Johnston, David A Schwartz, Athol U Wells,[...]. Am J Respir Crit Care Med 2014
280
6

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.
Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa, Connie P M Duong, Maryam Tidjani Alou, Romain Daillère, Aurélie Fluckiger, Meriem Messaoudene, Conrad Rauber, Maria P Roberti,[...]. Science 2018
6

[Can nivolumab be used safely in idiopathic pulmonary fibrosis?]
B Duchemann, M Didier, M-C Pailler, P-Y Brillet, M Kambouchner, Y Uzunhan, O Freynet, K Chouahnia, L Zelek, H Nunes. Rev Mal Respir 2019
9
22

The role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosis.
Friedrich Grimminger, Andreas Günther, Carlo Vancheri. Eur Respir J 2015
82
6

Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.
Giacomo Bellani, John G Laffey, Tài Pham, Eddy Fan, Laurent Brochard, Andres Esteban, Luciano Gattinoni, Frank van Haren, Anders Larsson, Daniel F McAuley,[...]. JAMA 2016
6

Novel therapeutic approaches for pulmonary fibrosis.
Arnab Datta, Chris J Scotton, Rachel C Chambers. Br J Pharmacol 2011
145
6

The impact of lung cancer on survival of idiopathic pulmonary fibrosis.
Sara Tomassetti, Christian Gurioli, Jay H Ryu, Paul A Decker, Claudia Ravaglia, Paola Tantalocco, Matteo Buccioli, Sara Piciucchi, Nicola Sverzellati, Alessandra Dubini,[...]. Chest 2015
165
6

Lung cancer in patients with idiopathic pulmonary fibrosis: clinical characteristics and impact on survival.
Taehoon Lee, Ji Young Park, Hong Yeul Lee, Young-Jae Cho, Ho Il Yoon, Jae Ho Lee, Sanghoon Jheon, Choon-Taek Lee, Jong Sun Park. Respir Med 2014
75
6

Vinorelbine and cisplatin in patients with advanced non-small cell lung cancer with interstitial pneumonia.
Naohiro Watanabe, Seiji Niho, Keisuke Kirita, Shigeki Umemura, Shingo Matsumoto, Kiyotaka Yoh, Hironobu Ohmatsu, Koichi Goto. Anticancer Res 2015
14
14

Pemetrexed Plus Platinum for Patients With Advanced Non-small Cell Lung Cancer and Interstitial Lung Disease.
Tetsuo Fujita, Tsuguko Kuroki, Nami Hayama, Yuka Shiraishi, Hiroyuki Amano, Makoto Nakamura, Satoshi Hirano, Hiroshi Tabeta, Sukeyuki Nakamura. In Vivo 2019
5
40

A prospective phase II study of carboplatin and nab-paclitaxel in patients with advanced non-small cell lung cancer and concomitant interstitial lung disease (HOT1302).
Hajime Asahina, Satoshi Oizumi, Kei Takamura, Toshiyuki Harada, Masao Harada, Hiroshi Yokouchi, Kenya Kanazawa, Yuka Fujita, Tetsuya Kojima, Fumiko Sugaya,[...]. Lung Cancer 2019
9
22



Gefitinib exposure and occurrence of interstitial lung disease in Japanese patients with non-small-cell lung cancer.
Toshio Kawata, Mitsuo Higashimori, Yohji Itoh, Helen Tomkinson, Martin G Johnson, Weifeng Tang, Fredrik Nyberg, Haiyi Jiang, Yusuke Tanigawara. Cancer Chemother Pharmacol 2019
8
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.